** Brokerage BMO Capital Markets raises price target on agrichemicals company Corteva CTVA.N to $86 from $74
** The new price target represents a nearly 10% upside to the stock's last close
** "We think the stock can continue to work as current attractive multiples keep getting rolled forward on a strong growth profile," - BMO says
** Brokerage adds CTVA can push over $90/shr if the company hits its 2027 EBITDA guidance range midpoint of $4.4 billion
** Shares of CTVA marginally down at $76.35 premarket
** 18 of 25 brokerages rate the stock "buy" or higher, and seven rate it "hold"; their median PT is $75.50 - LSEG Data
** As of last close, CTVA stock is up over 34% YTD
(Reporting by Vallari Srivastava in Bengaluru)
((Srivastava.Vallari@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。